+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Peptide Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 117 Pages
  • August 2023
  • Region: Global
  • Prof Research
  • ID: 5865375
Description Jump to:

Quick Summary:

In a rapidly evolving healthcare landscape, staying ahead is crucial. Recognizing patterns, identifying key players, and understanding market nuances can make or break strategic decisions. Within this complex matrix, one area demands particular attention - the realm of Peptide Therapeutics. With this meticulously compiled report, securing a competitive edge becomes significantly more manageable.

This comprehensive analysis offers invaluable insights into regional supply, demand, pricing, and the major contributors across North America, South America, Asia & Pacific, Europe, and MEA. It dives deep into the business profiles, SWOT analyses, revenue, gross margin and market share of key international competitors. It also highlights specific application segments like Cancer, Metabolic Disorders, Central Nervous System and more, with an overview of varying type segments such as injection, oral and others. Equip your organization with the knowledge to strategize effectively, optimizing crucial factors to harness the potential of the Peptide Therapeutics market.

This report describes the global market size of Peptide Therapeutics from 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028.

For the geography segment, regional supply, demand, major players, price is presented from 2018 to 2028.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Peptide Therapeutics as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Cancer
  • Metabolic Disorders
  • Central Nervous System
  • Other

Types Segment:

  • Injection
  • Oral
  • Other

Companies Covered:

  • Pfizer
  • Eli Lilly and Company
  • Bachem Holding
  • Amgen
  • Roche
  • GlaxoSmithKline
  • Novartis
  • Sanofi
  • Takeda Pharmaceutical Company
  • Teva Pharmaceutical
Base Year: 2023
Historical Data: from 2018 to 2022
Forecast Data: from 2023 to 2028


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Peptide Therapeutics Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Peptide Therapeutics Market in North America (2018-2028)
8.1 Peptide Therapeutics Market Size
8.2 Peptide Therapeutics Market by End Use
8.3 Competition by Players/Suppliers
8.4 Peptide Therapeutics Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Peptide Therapeutics Market in South America (2018-2028)
9.1 Peptide Therapeutics Market Size
9.2 Peptide Therapeutics Market by End Use
9.3 Competition by Players/Suppliers
9.4 Peptide Therapeutics Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Peptide Therapeutics Market in Asia & Pacific (2018-2028)
10.1 Peptide Therapeutics Market Size
10.2 Peptide Therapeutics Market by End Use
10.3 Competition by Players/Suppliers
10.4 Peptide Therapeutics Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Peptide Therapeutics Market in Europe (2018-2028)
11.1 Peptide Therapeutics Market Size
11.2 Peptide Therapeutics Market by End Use
11.3 Competition by Players/Suppliers
11.4 Peptide Therapeutics Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Peptide Therapeutics Market in MEA (2018-2028)
12.1 Peptide Therapeutics Market Size
12.2 Peptide Therapeutics Market by End Use
12.3 Competition by Players/Suppliers
12.4 Peptide Therapeutics Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Peptide Therapeutics Market (2018-2023)
13.1 Peptide Therapeutics Market Size
13.2 Peptide Therapeutics Market by End Use
13.3 Competition by Players/Suppliers
13.4 Peptide Therapeutics Market Size by Type
Chapter 14 Global Peptide Therapeutics Market Forecast (2023-2028)
14.1 Peptide Therapeutics Market Size Forecast
14.2 Peptide Therapeutics Application Forecast
14.3 Competition by Players/Suppliers
14.4 Peptide Therapeutics Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Peptide Therapeutics Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Peptide Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
15.2 Eli Lilly and Company
15.2.1 Company Profile
15.2.2 Main Business and Peptide Therapeutics Information
15.2.3 SWOT Analysis of Eli Lilly and Company
15.2.4 Eli Lilly and Company Peptide Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
15.3 Bachem Holding
15.3.1 Company Profile
15.3.2 Main Business and Peptide Therapeutics Information
15.3.3 SWOT Analysis of Bachem Holding
15.3.4 Bachem Holding Peptide Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
15.4 Amgen
15.4.1 Company Profile
15.4.2 Main Business and Peptide Therapeutics Information
15.4.3 SWOT Analysis of Amgen
15.4.4 Amgen Peptide Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
15.5 Roche
15.5.1 Company Profile
15.5.2 Main Business and Peptide Therapeutics Information
15.5.3 SWOT Analysis of Roche
15.5.4 Roche Peptide Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
15.6 GlaxoSmithKline
15.6.1 Company Profile
15.6.2 Main Business and Peptide Therapeutics Information
15.6.3 SWOT Analysis of GlaxoSmithKline
15.6.4 GlaxoSmithKline Peptide Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
15.7 Novartis
15.7.1 Company Profile
15.7.2 Main Business and Peptide Therapeutics Information
15.7.3 SWOT Analysis of Novartis
15.7.4 Novartis Peptide Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
15.8 Sanofi
15.8.1 Company Profile
15.8.2 Main Business and Peptide Therapeutics Information
15.8.3 SWOT Analysis of Sanofi
15.8.4 Sanofi Peptide Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
15.9 Takeda Pharmaceutical Company
15.9.1 Company Profile
15.9.2 Main Business and Peptide Therapeutics Information
15.9.3 SWOT Analysis of Takeda Pharmaceutical Company
15.9.4 Takeda Pharmaceutical Company Peptide Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
15.10 Teva Pharmaceutical
15.10.1 Company Profile
15.10.2 Main Business and Peptide Therapeutics Information
15.10.3 SWOT Analysis of Teva Pharmaceutical
15.10.4 Teva Pharmaceutical Peptide Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Peptide Therapeutics Report
Table Data Sources of Peptide Therapeutics Report
Table Major Assumptions of Peptide Therapeutics Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Peptide Therapeutics Picture
Table Peptide Therapeutics Classification
Table Peptide Therapeutics Applications
Table Drivers of Peptide Therapeutics Market
Table Restraints of Peptide Therapeutics Market
Table Opportunities of Peptide Therapeutics Market
Table Threats of Peptide Therapeutics Market
Table Covid-19 Impact For Peptide Therapeutics Market
Table Raw Materials Suppliers
Table Different Production Methods of Peptide Therapeutics
Table Cost Structure Analysis of Peptide Therapeutics
Table Key End Users
Table Latest News of Peptide Therapeutics Market
Table Merger and Acquisition
Table Planned/Future Project of Peptide Therapeutics Market
Table Policy of Peptide Therapeutics Market
Table 2018-2028 North America Peptide Therapeutics Market Size
Figure 2018-2028 North America Peptide Therapeutics Market Size and CAGR
Table 2018-2028 North America Peptide Therapeutics Market Size by Application
Table 2018-2023 North America Peptide Therapeutics Key Players Revenue
Table 2018-2023 North America Peptide Therapeutics Key Players Market Share
Table 2018-2028 North America Peptide Therapeutics Market Size by Type
Table 2018-2028 United States Peptide Therapeutics Market Size
Table 2018-2028 Canada Peptide Therapeutics Market Size
Table 2018-2028 Mexico Peptide Therapeutics Market Size
Table 2018-2028 South America Peptide Therapeutics Market Size
Figure 2018-2028 South America Peptide Therapeutics Market Size and CAGR
Table 2018-2028 South America Peptide Therapeutics Market Size by Application
Table 2018-2023 South America Peptide Therapeutics Key Players Revenue
Table 2018-2023 South America Peptide Therapeutics Key Players Market Share
Table 2018-2028 South America Peptide Therapeutics Market Size by Type
Table 2018-2028 Brazil Peptide Therapeutics Market Size
Table 2018-2028 Argentina Peptide Therapeutics Market Size
Table 2018-2028 Chile Peptide Therapeutics Market Size
Table 2018-2028 Peru Peptide Therapeutics Market Size
Table 2018-2028 Asia & Pacific Peptide Therapeutics Market Size
Figure 2018-2028 Asia & Pacific Peptide Therapeutics Market Size and CAGR
Table 2018-2028 Asia & Pacific Peptide Therapeutics Market Size by Application
Table 2018-2023 Asia & Pacific Peptide Therapeutics Key Players Revenue
Table 2018-2023 Asia & Pacific Peptide Therapeutics Key Players Market Share
Table 2018-2028 Asia & Pacific Peptide Therapeutics Market Size by Type
Table 2018-2028 China Peptide Therapeutics Market Size
Table 2018-2028 India Peptide Therapeutics Market Size
Table 2018-2028 Japan Peptide Therapeutics Market Size
Table 2018-2028 South Korea Peptide Therapeutics Market Size
Table 2018-2028 Southeast Asia Peptide Therapeutics Market Size
Table 2018-2028 Australia Peptide Therapeutics Market Size
Table 2018-2028 Europe Peptide Therapeutics Market Size
Figure 2018-2028 Europe Peptide Therapeutics Market Size and CAGR
Table 2018-2028 Europe Peptide Therapeutics Market Size by Application
Table 2018-2023 Europe Peptide Therapeutics Key Players Revenue
Table 2018-2023 Europe Peptide Therapeutics Key Players Market Share
Table 2018-2028 Europe Peptide Therapeutics Market Size by Type
Table 2018-2028 Germany Peptide Therapeutics Market Size
Table 2018-2028 France Peptide Therapeutics Market Size
Table 2018-2028 United Kingdom Peptide Therapeutics Market Size
Table 2018-2028 Italy Peptide Therapeutics Market Size
Table 2018-2028 Spain Peptide Therapeutics Market Size
Table 2018-2028 Belgium Peptide Therapeutics Market Size
Table 2018-2028 Netherlands Peptide Therapeutics Market Size
Table 2018-2028 Austria Peptide Therapeutics Market Size
Table 2018-2028 Poland Peptide Therapeutics Market Size
Table 2018-2028 Russia Peptide Therapeutics Market Size
Table 2018-2028 MEA Peptide Therapeutics Market Size
Figure 2018-2028 MEA Peptide Therapeutics Market Size and CAGR
Table 2018-2028 MEA Peptide Therapeutics Market Size by Application
Table 2018-2023 MEA Peptide Therapeutics Key Players Revenue
Table 2018-2023 MEA Peptide Therapeutics Key Players Market Share
Table 2018-2028 MEA Peptide Therapeutics Market Size by Type
Table 2018-2028 Egypt Peptide Therapeutics Market Size
Table 2018-2028 Israel Peptide Therapeutics Market Size
Table 2018-2028 South Africa Peptide Therapeutics Market Size
Table 2018-2028 Gulf Cooperation Council Countries Peptide Therapeutics Market Size
Table 2018-2028 Turkey Peptide Therapeutics Market Size
Table 2018-2023 Global Peptide Therapeutics Market Size by Region
Table 2018-2023 Global Peptide Therapeutics Market Size Share by Region
Table 2018-2023 Global Peptide Therapeutics Market Size by Application
Table 2018-2023 Global Peptide Therapeutics Market Share by Application
Table 2018-2023 Global Peptide Therapeutics Key Vendors Revenue
Figure 2018-2023 Global Peptide Therapeutics Market Size and Growth Rate
Table 2018-2023 Global Peptide Therapeutics Key Vendors Market Share
Table 2018-2023 Global Peptide Therapeutics Market Size by Type
Table 2018-2023 Global Peptide Therapeutics Market Share by Type
Table 2023-2028 Global Peptide Therapeutics Market Size by Region
Table 2023-2028 Global Peptide Therapeutics Market Size Share by Region
Table 2023-2028 Global Peptide Therapeutics Market Size by Application
Table 2023-2028 Global Peptide Therapeutics Market Share by Application
Table 2023-2028 Global Peptide Therapeutics Key Vendors Revenue
Figure 2023-2028 Global Peptide Therapeutics Market Size and Growth Rate
Table 2023-2028 Global Peptide Therapeutics Key Vendors Market Share
Table 2023-2028 Global Peptide Therapeutics Market Size by Type
Table 2023-2028 Peptide Therapeutics Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Pfizer
  • Eli Lilly and Company
  • Bachem Holding
  • Amgen
  • Roche
  • GlaxoSmithKline
  • Novartis
  • Sanofi
  • Takeda Pharmaceutical Company
  • Teva Pharmaceutical

Methodology

Loading
LOADING...

Related Topics

Related Reports

Peptide Therapeutics Global Market Report 2024 - Product Image

Peptide Therapeutics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Peptide Therapeutics Market by Technology (Hybrid Phase, Liquid Phase, Solid Phase), Drug Class (Adrenocorticotropic Hormone, Calcitonin, Insulin), Route of Administration, Application, End User, Manufacturing Type - Forecast 2024-2030 - Product Image

Global Peptide Therapeutics Market by Technology (Hybrid Phase, Liquid Phase, Solid Phase), Drug Class (Adrenocorticotropic Hormone, Calcitonin, Insulin), Route of Administration, Application, End User, Manufacturing Type - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Global Peptide Therapeutics Market Size, Share & Trends Analysis Report by Application (Cancer, Metabolic Disorders), Type (Generic, Innovative), Type of Manufacturer, Route of Administration, Synthesis Technology, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Peptide Therapeutics Market Size, Share & Trends Analysis Report by Application (Cancer, Metabolic Disorders), Type (Generic, Innovative), Type of Manufacturer, Route of Administration, Synthesis Technology, Region, and Segment Forecasts, 2024-2030

  • Report
  • 110 Pages
  • Global
From
Peptide Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Peptide Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Peptide Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Peptide Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.